PATENT CLAIM ANALYSIS

Application Number: 16331691
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "005900"]

Abstract:
A method of treating a subject for acute nicotine withdrawal generally includes intranasally administering to the subject a dose of insulin effective to ameliorate at least one symptom or clinical sign of nicotine withdrawal. In some embodiments, the dose of insulin can be at least 45 IU and no more than 75 IU. In one particular embodiment, the dose can be 60 IU. In some embodiments, the dose can be an amount effective to restore at least a portion of a nicotine-withdrawal-associated decrease in saliva Cortisol level following a stress stimulus. In some embodiments, the dose can be an amount effective to decrease an urge to smoke a cigarette during cute withdrawal from nicotine.

Claim (Index 1):
A method of treating a subject in need of treatment for acute nicotine withdrawal, the method comprising:\n intranasally administering to the subject a dose of insulin effective to ameliorate at least one symptom or clinical sign of nicotine withdrawal.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 99.0
- Lexical Diversity: 1.95238
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15007525', '15601240', '15231239', '14404878', '14624376']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6562854703779993
- 35 USC 102 Novelty (BERT): 0.4811709373467779
- Combined Prediction Score: 0.6387740170748771
- Mean Citation Score: 143.810288
- Max Citation Score: 147.1265
- Similarity Product: 104.429513487339

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test